Zohar Barbash

Zohar Barbash is currently the Chief Technology Officer at Wilk, where Zohar leads the R&D effort and promotes upscaling tasks, regulatory approvals, and collaborations with other companies. Prior to their current role, Zohar held positions at Fore Biotherapeutics as VP Research and Development, Novellus DX as Director of Assay Development, Eventus Dx as a Researcher, the National Cancer Institute as a PostDoc, and Sheba Medical Center at Tel Hashomer as a lab Technician. Zohar's educational background includes a B.Sc. in Psychobiology from The Hebrew University of Jerusalem, an M.Sc. in human genetics and a PhD in Molecular Genetics from Tel Aviv University.